Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gleevec in Ewing's Family of Tumors and DSRCT
NCT00062205Phase 2Completed
- Sponsor
- City of Hope
- Start
- Jun 2002
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in Ewing sarcoma, desmoplastic small round cell tumor (DSRCT), sponsored by City of Hope. Started Jun 2002; status: completed.
02
Drugs
03
Conditions
Ewing sarcomadesmoplastic small round cell tumor (DSRCT)
Beyond the preview
Go deeper on NCT00062205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00062205.